Alert button
Picture for Alexander Partin

Alexander Partin

Alert button

Division of Data Science and Learning, Argonne National Laboratory, Argonne, IL, USA

Deep learning methods for drug response prediction in cancer: predominant and emerging trends

Nov 18, 2022
Alexander Partin, Thomas S. Brettin, Yitan Zhu, Oleksandr Narykov, Austin Clyde, Jamie Overbeek, Rick L. Stevens

Figure 1 for Deep learning methods for drug response prediction in cancer: predominant and emerging trends
Figure 2 for Deep learning methods for drug response prediction in cancer: predominant and emerging trends
Figure 3 for Deep learning methods for drug response prediction in cancer: predominant and emerging trends
Figure 4 for Deep learning methods for drug response prediction in cancer: predominant and emerging trends
Viaarxiv icon

Protein-Ligand Docking Surrogate Models: A SARS-CoV-2 Benchmark for Deep Learning Accelerated Virtual Screening

Jun 30, 2021
Austin Clyde, Thomas Brettin, Alexander Partin, Hyunseung Yoo, Yadu Babuji, Ben Blaiszik, Andre Merzky, Matteo Turilli, Shantenu Jha, Arvind Ramanathan, Rick Stevens

Figure 1 for Protein-Ligand Docking Surrogate Models: A SARS-CoV-2 Benchmark for Deep Learning Accelerated Virtual Screening
Figure 2 for Protein-Ligand Docking Surrogate Models: A SARS-CoV-2 Benchmark for Deep Learning Accelerated Virtual Screening
Figure 3 for Protein-Ligand Docking Surrogate Models: A SARS-CoV-2 Benchmark for Deep Learning Accelerated Virtual Screening
Figure 4 for Protein-Ligand Docking Surrogate Models: A SARS-CoV-2 Benchmark for Deep Learning Accelerated Virtual Screening
Viaarxiv icon

Pandemic Drugs at Pandemic Speed: Accelerating COVID-19 Drug Discovery with Hybrid Machine Learning- and Physics-based Simulations on High Performance Computers

Mar 04, 2021
Agastya P. Bhati, Shunzhou Wan, Dario Alfè, Austin R. Clyde, Mathis Bode, Li Tan, Mikhail Titov, Andre Merzky, Matteo Turilli, Shantenu Jha, Roger R. Highfield, Walter Rocchia, Nicola Scafuri, Sauro Succi, Dieter Kranzlmüller, Gerald Mathias, David Wifling, Yann Donon, Alberto Di Meglio, Sofia Vallecorsa, Heng Ma, Anda Trifan, Arvind Ramanathan, Tom Brettin, Alexander Partin, Fangfang Xia, Xiaotan Duan, Rick Stevens, Peter V. Coveney

Figure 1 for Pandemic Drugs at Pandemic Speed: Accelerating COVID-19 Drug Discovery with Hybrid Machine Learning- and Physics-based Simulations on High Performance Computers
Figure 2 for Pandemic Drugs at Pandemic Speed: Accelerating COVID-19 Drug Discovery with Hybrid Machine Learning- and Physics-based Simulations on High Performance Computers
Figure 3 for Pandemic Drugs at Pandemic Speed: Accelerating COVID-19 Drug Discovery with Hybrid Machine Learning- and Physics-based Simulations on High Performance Computers
Figure 4 for Pandemic Drugs at Pandemic Speed: Accelerating COVID-19 Drug Discovery with Hybrid Machine Learning- and Physics-based Simulations on High Performance Computers
Viaarxiv icon

Learning Curves for Drug Response Prediction in Cancer Cell Lines

Nov 25, 2020
Alexander Partin, Thomas Brettin, Yvonne A. Evrard, Yitan Zhu, Hyunseung Yoo, Fangfang Xia, Songhao Jiang, Austin Clyde, Maulik Shukla, Michael Fonstein, James H. Doroshow, Rick Stevens

Figure 1 for Learning Curves for Drug Response Prediction in Cancer Cell Lines
Figure 2 for Learning Curves for Drug Response Prediction in Cancer Cell Lines
Figure 3 for Learning Curves for Drug Response Prediction in Cancer Cell Lines
Figure 4 for Learning Curves for Drug Response Prediction in Cancer Cell Lines
Viaarxiv icon

Ensemble Transfer Learning for the Prediction of Anti-Cancer Drug Response

May 13, 2020
Yitan Zhu, Thomas Brettin, Yvonne A. Evrard, Alexander Partin, Fangfang Xia, Maulik Shukla, Hyunseung Yoo, James H. Doroshow, Rick Stevens

Figure 1 for Ensemble Transfer Learning for the Prediction of Anti-Cancer Drug Response
Figure 2 for Ensemble Transfer Learning for the Prediction of Anti-Cancer Drug Response
Figure 3 for Ensemble Transfer Learning for the Prediction of Anti-Cancer Drug Response
Figure 4 for Ensemble Transfer Learning for the Prediction of Anti-Cancer Drug Response
Viaarxiv icon

A Systematic Approach to Featurization for Cancer Drug Sensitivity Predictions with Deep Learning

May 04, 2020
Austin Clyde, Tom Brettin, Alexander Partin, Maulik Shaulik, Hyunseung Yoo, Yvonne Evrard, Yitan Zhu, Fangfang Xia, Rick Stevens

Figure 1 for A Systematic Approach to Featurization for Cancer Drug Sensitivity Predictions with Deep Learning
Figure 2 for A Systematic Approach to Featurization for Cancer Drug Sensitivity Predictions with Deep Learning
Figure 3 for A Systematic Approach to Featurization for Cancer Drug Sensitivity Predictions with Deep Learning
Figure 4 for A Systematic Approach to Featurization for Cancer Drug Sensitivity Predictions with Deep Learning
Viaarxiv icon